Black Titan Corp (NASDAQ:BTTC) Stock Short Interest Report for September

Black Titan Corp (NASDAQ:BTTC – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 324,159 shares, an increase of 2,988.7% from the September 15th total of 10,495 shares. Based on an average daily volume of 49,519,007 shares, the days-to-cover ratio is presently 0.0 days. Approximately 6.5% of the company’s stock are sold short.

Black Titan Stock Performance

Shares of Black Titan stock opened at $0.48 on Friday. The business has a 50-day simple moving average of $0.54 and a 200-day simple moving average of $0.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.62 and a current ratio of 4.62. Black Titan has a one year low of $0.34 and a one year high of $10.05. The company has a market cap of $5.13 million, a PE ratio of -0.16 and a beta of 1.11.

Get Black Titan alerts:

About Black Titan

(Get Free Report)

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.

Featured Articles

• Five stocks we like better than Black Titan
• Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
• Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
• Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
• Arista Networks Plugs Into All-Time Highs

Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.